Clinical Trials Insight: 700009514
Latest Information Update: 30 Nov 2005
At a glance
- Drugs PI-166 (Primary)
- Indications Liver cancer
- Focus Adverse reactions
- Sponsors Progen Pharmaceuticals Limited
Most Recent Events
- 30 Nov 2005 New trial record.